Report
Rayhan Ahmed

IPO Note on Asiatic Laboratories Limited (ASIATICLAB)

ASIATICLAB manufactures and sells a wide range of Biological & Non-Biological pharmaceuticals products in the dosage form of tablets, capsules, syrups, creams, injections etc. in the local & international market (10 countries). Based on the geographic location of the market, ASIATICLAB derived the majority of its revenue from local market, constituted 90.2% of its total revenue for the period of FY’22, which was 66.7% of total revenue as on FY’21. The company generated rest of the revenue from the export market, accounted for 9.8% of total revenue as on FY’22, compared to 33.3% of total revenue as on FY’21.

Provider
EBL Securities Ltd.
EBL Securities Ltd.

EBL Securities Ltd. (EBLSL) is one of the fastest growing full-service institutional brokerage companies in Bangladesh. On top of our expertise and achievements, we take pride in our strong commitment towards excellent client services and development of the Bangladesh capital markets.

EBLSL is a fully owned subsidiary of Eastern Bank Limited (EBL), one of the leading private commercial banks of Bangladesh. EBLSL is one of the TOP-10 brokerage companies of Bangladesh.

We have unwavering faith in the potential of Bangladesh. We also believe that an efficient, vibrant and transparent capital market can strongly contribute to the overall development of Bangladesh. Bangladesh is currently at the initial stage of capital market growth, and we are committed to assist the entry of early movers into a growth-oriented, vibrant, nascent emerging market.

EBLSL has developed a disciplined approach towards providing capital market services. The foundation for our business is a strong commitment towards market experience & professionalism, investment knowledge, market intelligence and research services.

Analysts
Rayhan Ahmed

Other Reports from EBL Securities Ltd.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch